Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Pneumococcal vaccine study for toddlers 12 to 15 months old

      We’re working closely with pediatricians and researchers to expand protection for toddlers against pneumococcal disease.

      Learn more

      19 trials found for breast cancer

      All(19)
      Recruiting(18)
      Not yet recruiting(1)
      2 trials recruiting
      Pfizer Breast Cancer Clinical Trials

      Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

      Recruiting
      NCT06105632
      A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

      Advanced or Metastatic Breast Cancer

      Male or Female
      18+ years
      486study location(s)
      Recruiting
      NCT06206837
      A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

      Breast Cancer

      Male or Female
      18+ years
      114study location(s)
      Recruiting
      NCT06125522
      TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

      Breast Cancer

      Male or Female
      18+ years
      94study location(s)
      Recruiting
      NCT05573555
      TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

      Breast Cancer

      Male or Female
      18+ years
      90study location(s)
      Recruiting
      NCT06157892
      A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors

      Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Advanced Breast

      Male or Female
      18+ years
      39study location(s)
      Recruiting
      NCT06465368
      A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

      Breast Cancer

      Females
      18+ years
      56study location(s)
      Recruiting
      NCT04557449
      Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

      Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung

      Male or Female
      18+ years
      92study location(s)
      Recruiting
      NCT04389632
      A Study of SGN-B6A in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      44study location(s)
      Recruiting
      NCT05194072
      A Study of SGN-B7H4V in Advanced Solid Tumors

      Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms, Triple Negative Breast Neoplasms, HER2 Negative Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung,

      Male or Female
      18+ years
      19study location(s)
      Recruiting
      NCT05226871
      Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

      Breast Cancer, Head and Neck Cancer

      Male or Female
      18+ years
      32study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(19)
      Recruiting(18)
      Not yet recruiting(1)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.